NCT04758520

Brief Summary

The purpose of this pilot study is to validate the safety, reliability and usability of FLOAT medical device, a prototypal robotic system for the rehabilitation of the shoulder, designed and developed in the Rehab Technologies IIT-INAIL Lab to fulfil the needs orthopaedic conditions. The acceptance from patients and therapists will be assessed after a single session of robotic therapy in a sample of injured workers suffering from post-traumatic or post-surgical shoulder disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 9, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 17, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 21, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 21, 2022

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

1.3 years

First QC Date

February 9, 2021

Last Update Submit

March 29, 2022

Conditions

Keywords

AdultDeseases/musculoskeletalFeasibility StudiesHumansOccupational TherapyRehabilitation ResearchRoboticsShoulder Joint / therapyUpper arm/therapyWearable devices

Outcome Measures

Primary Outcomes (2)

  • Number of adverse events

    The physiotherapist is required to report any adverse events occurring during the study in regard to the use of FLOAT, for the purpose of evaluating the safety of the device

    1 year

  • Number of device malfunctions

    The physiotherapist is required to report any malfunctions occurring during the study in regard to the use of FLOAT, for the purpose of evaluating the reliability of the device

    1 year

Secondary Outcomes (6)

  • Numeric Pain Rating Scale (NPRS)

    1 year

  • The Borg Category-Ratio Scale (CR-10)

    1 year

  • Ad-hoc questionnaires for the patient, one for each of the three modalities (for a total amount of 3 questionnaires)

    After the completion of the testing session with each of the three modalities

  • Ad-hoc questionnaires for the therapist, one for each of the three modalities (for a total amount of 3 questionnaires)

    1 year

  • Ad-hoc questionnaire for the patient (final evaluation)

    1 year (at the end of the study)

  • +1 more secondary outcomes

Study Arms (1)

Experimental

EXPERIMENTAL

Six subjects are involved in a single session of upper limb robotic-assisted therapy lasting about 3 hours and including: * passive mobilization of patient's upper arm along elementary shoulder movements:shoulder flexion/extension, adduction/ abduction in the frontal plane, horizontal adduction/ abduction, intra/extrarotation (Passive Mode); * passive mobilization of patient's upper arm along complex trajectories recorded from manual mobilization of the therapist (Learn\&Replay Mode); * active mobilization, performed by the patient during rehabilitative functional tasks, relying only on gravity and friction compensations and tuneable assistance from the exoskeleton (Transparency Mode).

Device: FLOAT upper limb exoskeleton

Interventions

The FLOAT device is composed by a wearable exoskeleton assembled on a poly-articulated arm that, in turn, is mounted on a support base with unlockable wheels. The exoskeleton includes 5 motors arranged in a way that, when generating movement, ensures the optimal involvement of all the articulations of the shoulder complex, particularly the glenohumeral and the scapulothoracic joints. According to the chosen modality of use of the exoskeleton, the device allows patient's passive or active-assisted mobilization. The poly-articulated arm supporting the exoskeleton is capable to compensate exoskeleton weight in every configuration and, if configured appropriately, permits exoskeleton use both in seated and standing positions. The support base of the device has unlockable wheels that, if unlocked, permit the free movement of the patient in the workspace, enabling the performance of more complex functional activities while assisted by the exoskeleton.

Experimental

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Height between 160 and 185 cm;
  • Distance between the shoulder joint center and the sagittal plane between 156 and 197 mm;
  • Shoulder joint center to wall distance between 82 and 142 mm
  • Maximum shoulter radius: 120 mm
  • Distance between the shoulder joint center and the elbow joint center between 250 and 303 mm
  • Time from acute event ≥ 60 days
  • Right shoulder joint disfunction after orthopaedic injury or surgery as a result of work accidents
  • Post-immobilization phase
  • At least 80° shoulder passive flexion and 45° shoulder passive abduction
  • Pain intensity on movement \< 6 NRS;

You may not qualify if:

  • Glenohumeral joint instability
  • Shoulder Prosthetic implants
  • Upper arm sensorimotor deficits
  • Chronic inflammatory disorder involving upper arm joints
  • Pseudoarthrosis of the proximal humerus fractures
  • Spinal fractures within the last 3 months
  • Open skin at the level of the patient-device interface
  • Current or prior history of malignancy
  • Pregnancy or breast feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

INAIL - Centro di Riabilitazione Motoria di Volterra

Volterra, Pisa, 56048, Italy

Location

MeSH Terms

Conditions

Shoulder InjuriesDisease

Condition Hierarchy (Ancestors)

Wounds and InjuriesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Elisa Taglione, MD

    Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Model Details: Single Group Assignment
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2021

First Posted

February 17, 2021

Study Start

November 20, 2020

Primary Completion

February 21, 2022

Study Completion

February 21, 2022

Last Updated

March 31, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations